To determine if ZnF-dependent abilities of MdmX to suppress multipolar mitosis and chromosomal loss can impact tumor progression, we employed MB231 cells, a p53-mutant human breast cancer cell line frequently used in orthotopic tumor transplantation studies transduced with MdmX constructs. Here, MDM4 is linked to breast carcinoma.